Ultrasound in Medicine and Biology
Volume 33, Issue 2 , Pages 235-245 , February 2007

Quantitative contrast enhanced ultrasound and ct assessment of tumor response to antiangiogenic therapy in rats

  • Rachel E. Pollard

      Affiliations

    • Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis CA, USA
    • Corresponding Author InformationAddress correspondence to: Rachel E. Pollard, DVM, PhD, Department of Surgical and Radiological Sciences, University of California, Davis, School of Veterinary Medicine, Davis, CA 95616 USA.
    • ,
  • Amy R. Broumas

      Affiliations

    • Department of Biomedical Engineering, University of California, Davis, CA, USA
    • ,
  • Erik R. Wisner

      Affiliations

    • Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis CA, USA
    • ,
  • Sylvia V. Vekich

      Affiliations

    • Pfizer Global Research and Development, La Jolla, CA, USA
    • ,
  • Katherine W. Ferrara

      Affiliations

    • Department of Biomedical Engineering, University of California, Davis, CA, USA

Received 2 May 2006 ,Revised 17 July 2006 ,Accepted 27 July 2006.

References 

  1. Aronen HJ, Cohen MS, Belliveau JW, Fordham JA, Rosen BR. Ultrafast imaging of brain tumors. Top Magn Reson Imaging. 1993;5(1):14–24
  2. Arora N, Masood R, Zheng T, et al. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells. Cancer Res. 1999;59(1):183–188
  3. Atiqur Rahman M, Toi M. Anti-angiogenic therapy in breast cancer. Biomed Pharmacother. 2003;57(10):463–470
  4. Brasch R, Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur J Radiol. 2000;34(3):148–155
  5. Brasch RC, Gossmann A, Helbich TH, et al. Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?. Acad Radiol. 2002;2(Suppl. 9):S326–S327
  6. Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT-initial experience. Radiology. 1999;210(1):269–276
  7. Broumas AR, Pollard RE, Bloch SH, et al. Contrast-enhanced computed tomography and ultrasound for the evaluation of tumor blood flow. Invest Radiol. 2005;40(3):134–147
  8. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: Improved method for characterizing focal masses with microbubble contrast. Invest Radiol. 2000;35(1):58–71
  9. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. Dynamic CT measurement of cerebral blood flow: Validation study. AJNR Am J Neuroradiol. 1999;20(1):63–73
  10. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. A CT method to measure hemodynamics in brain tumors: Validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol. 2000;21(3):462–470
  11. Chomas JE, Dayton P, Allen J, Morgan K, Ferrara KW. Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control. 2001;48(1):232–248
  12. Chomas JE, Pollard RE, Sadlowski AR, et al. Contrast-enhanced US of microcirculation of superficially implanted tumors in rats. Radiology. 2003;229(2):439–446
  13. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol. 1998;171(4):941–949
  14. Douglas ML, Reid JL, Hii SI, Jonsson JR, Nicol DL. Renal cell carcinoma may adapt to and overcome anti-angiogenic intervention with thalidomide. BJU Int. 2002;89(6):591–595
  15. Esserman L, Hylton N, George T, Weidner N. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J. 1999;5(1):13–21
  16. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging. 1999;10(3):254–259
  17. Ferrone M, Motl SE. Trastuzumab for the treatment of non-small-cell lung cancer. Ann Pharmacother. 2003;37(12):1904–1908
  18. Forsberg F, Shi WT, Goldberg BB. Subharmonic imaging of contrast agents. Ultrasonics. 2000;38(1–8):93–98
  19. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966;50(4):219–244
  20. Garofalo A, Naumova E, Manenti L, et al. The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically. Clin Cancer Res. 2003;9(9):3476–3485
  21. Hirata M, Sugawara Y, Fukutomi Y, et al. Measurement of radiation dose in cerebral CT perfusion study. Radiat Med. 2005;23(2):97–103
  22. Kiessling F, Boese J, Corvinus C, et al. Perfusion CT in patients with advanced bronchial carcinomas: A novel chance for characterization and treatment monitoring?. Eur Radiol. 2004;14(7):1226–133
  23. Krix M, Kiessling F, Vosseler S, et al. Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography. Cancer Res. 2003;63(23):8264–8270
  24. Laird AD, Vajkoczy P, Shawver LK, et al. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res. 2000;60(15):4152–4160
  25. Margolin K, Gordon MS, Holmgren E, et al. Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data. J Clin Oncol. 2001;19(3):851–856
  26. Miles KA, Leggett DA, Bennett GA. CT derived Patlak images of the human kidney. Br J Radiol. 1999;72(854):153–158
  27. Nabavi DG, Cenic A, Henderson S, Gelb AW, Lee TY. Perfusion mapping using computed tomography allows accurate prediction of cerebral infarction in experimental brain ischemia. Stroke. 2001;32(1):175–183
  28. Netti PA, Roberge S, Boucher Y, Baxter LT, Jain RK. Effect of transvascular fluid exchange on pressure-flow relationship in tumors: A proposed mechanism for tumor blood flow heterogeneity. Microvasc Res. 1996;52(1):27–46
  29. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple- time uptake data. J Cereb Blood Flow Metab. 1983;3(1):1–7
  30. Pollard RE, Garcia TC, Stieger SM, et al. Quantitative evaluation of perfusion and permeability of peripheral tumors using contrast-enhanced computed tomography. Invest Radiol. 2004;39(6):340–349
  31. Pollard RE, Sadlowski AR, Bloch SH, et al. Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rat model. Technol Cancer Res Treat. 2002;1(6):459–470
  32. Sadlowski A, Chomas J, Pollard R. Mean flow rate and integrated perfusion estimates obtained with contrast-assisted ultrasound (IEEE Proceedings). 2002;Munich, Germany
  33. Sboros V, Moran CM, Pye SD, McDicken WN. Contrast agent stability: A continuous B-mode imaging approach. Ultrasound Med Biol. 2001;27(10):1367–1377
  34. Tiemann K, Veltmann C, Ghanem A, et al. The impact of emission power on the destruction of echo contrast agents and on the origin of tissue harmonic signals using power pulse-inversion imaging. Ultrasound Med Biol. 2001;27(11):1525–1533
  35. Traxler P. Tyrosine kinases as targets in cancer therapy—successes and failures. Expert Opin Ther Targets. 2003;7(2):215–234
  36. Wedge SR, Ogilvie DJ, Dukes M, et al. ZD4190: An orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy. Cancer Res. 2000;60(4):970–975
  37. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998;97(5):473–483

PII: S0301-5629(06)01778-9

doi: 10.1016/j.ultrasmedbio.2006.07.036

Ultrasound in Medicine and Biology
Volume 33, Issue 2 , Pages 235-245 , February 2007

Article Tools

* Image Usage & Resolution